Grifols (GIKLY) Change in Receivables (2010 - 2020)

Grifols (GIKLY) reported Change in Receivables of $1.5 million for Q1 2020, up 100.9% on a YoY basis from $738505.3 in Q2 2019, and up 109.81% quarter-over-quarter from -$15.1 million in Q4 2019.

Grifols (GIKLY) Change in Receivables (2010 - 2020) Analysis & Trends

Grifols has reported Change in Receivables for 10 years, with the latest figure at $1.5 million in Q1 2020.

  • For the quarter ending Q1 2020, Change in Receivables rose 100.9% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2020 stood at -$160.7 million (up 27.66% YoY), and the FY2025 full-year result was -$37.2 million, up 17.0% from the prior year.
  • Change in Receivables for Q1 2020 stood at $1.5 million, up from -$15.1 million in the prior quarter.
  • The five-year high for Change in Receivables was $81.5 million in Q4 2017, with the low at -$163.9 million in Q1 2019.
  • Historically, Change in Receivables has averaged -$4.0 million across 5 years, with a median of $3.5 million in 2016.
  • Annual changes were most pronounced in 2017 — Change in Receivables soared 2206.94% — and 2019, when it plunged 1195.73%.
  • Grifols' Change in Receivables stood at $3.5 million in 2016, then soared by 2206.94% to $81.5 million in 2017, then plunged by 79.25% to $16.9 million in 2018, then sank by 189.44% to -$15.1 million in 2019, then surged by 109.81% to $1.5 million in 2020.
  • The last three Change in Receivables figures came in at $1.5 million (Q1 2020), -$15.1 million (Q4 2019), and -$163.9 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 595.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -87.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -134.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -1.69 Bn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 1.48 Mn
Mar 31, 2020 1.48 Mn
Dec 31, 2019 -15.12 Mn
Dec 31, 2019 -15.12 Mn
Mar 31, 2019 -163.95 Mn
Mar 31, 2019 -163.95 Mn
Dec 31, 2018 16.91 Mn
Dec 31, 2018 16.91 Mn
Jun 30, 2018 -90.04 Mn
Jun 30, 2018 -90.04 Mn
Mar 31, 2018 14.96 Mn
Mar 31, 2018 14.96 Mn
Dec 31, 2017 81.48 Mn
Dec 31, 2017 81.48 Mn
Jun 30, 2017 -19.98 Mn
Jun 30, 2017 -19.98 Mn
Mar 31, 2017 61.00 Mn
Mar 31, 2017 61.00 Mn
Dec 31, 2016 3.53 Mn
Dec 31, 2016 3.53 Mn